Literature DB >> 8460726

Sentinel surveillance for HIV-2 infection in high-risk US populations.

I M Onorato1, T R O'Brien, C A Schable, C Spruill, S D Holmberg.   

Abstract

OBJECTIVES: We conducted sentinel surveillance in persons practicing behaviors known to transmit retroviruses to determine the US presence and extent of human immunodeficiency virus type 2 (HIV-2).
METHODS: Sentinel surveillance for HIV-2 was conducted by testing 31,533 anonymous blood specimens from patients at sexually transmitted disease clinics, injecting drug users at treatment centers, and clients at HIV counseling and testing sites in 14 US cities where West African immigrants often settle. Specimens were tested by HIV-1 and HIV-2 whole virus and synthetic peptide enzyme immunoassay and confirmed by HIV-1 and HIV-2 Western blots.
RESULTS: Nearly 10% of 31,533 sera were positive for HIV-1. Two heterosexual Black male sexually transmitted disease patients were infected with HIV-2. One of the HIV-2 positive specimens did not cross-react on HIV-1 enzyme immunoassay screening. One client had antibodies consistent with malarial infection in West Africa; the other, who had syphilis, did not have antibodies to malaria or to any of 20 arboviruses present in Africa.
CONCLUSIONS: Clinics serving clients from HIV-2 endemic areas should test persons practicing risk behaviors for both HIV-1 and HIV-2. Sentinel surveillance for HIV-2 serves as an early warning system for the possible spread of this virus in the United States.

Entities:  

Mesh:

Year:  1993        PMID: 8460726      PMCID: PMC1694477          DOI: 10.2105/ajph.83.4.515

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  10 in total

1.  Human immunodeficiency virus type 2 infection in the United States. Epidemiology, diagnosis, and public health implications.

Authors:  T R O'Brien; J R George; S D Holmberg
Journal:  JAMA       Date:  1992-05-27       Impact factor: 56.272

2.  HIV seroprevalence surveys in sexually transmitted disease clinics.

Authors:  I M Onorato; E McCray; M Pappaioanou; R Johnson; S Aral; A M Hardy; T J Dondero
Journal:  Public Health Rep       Date:  1990 Mar-Apr       Impact factor: 2.792

3.  Sensitivity of six commercial enzyme immunoassay kits that detect both anti-HIV-1 and anti-HIV-2.

Authors:  J V Parry; L McAlpine; M F Avillez
Journal:  AIDS       Date:  1990-04       Impact factor: 4.177

4.  HIV seroprevalence surveys in drug treatment centers.

Authors:  T S Jones; D M Allen; I M Onorato; L R Petersen; T J Dondero; M Pappaioanou
Journal:  Public Health Rep       Date:  1990 Mar-Apr       Impact factor: 2.792

5.  HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987.

Authors:  D C Des Jarlais; S R Friedman; D M Novick; J L Sotheran; P Thomas; S R Yancovitz; D Mildvan; J Weber; M J Kreek; R Maslansky
Journal:  JAMA       Date:  1989-02-17       Impact factor: 56.272

6.  Rapid and specific diagnosis of HIV-1 and HIV-2 infections: an evaluation of testing strategies.

Authors:  K M De Cock; A Porter; J Kouadio; M Maran; E Gnaore; G Adjorlolo; M F Lafontaine; G Bretton; G M Damet; K Odehouri
Journal:  AIDS       Date:  1990-09       Impact factor: 4.177

7.  The family of HIV seroprevalence surveys: objectives, methods, and uses of sentinel surveillance for HIV in the United States.

Authors:  M Pappaioanou; T J Dondero; L R Petersen; I M Onorato; C D Sanchez; J W Curran
Journal:  Public Health Rep       Date:  1990 Mar-Apr       Impact factor: 2.792

8.  Efficacies of US Food and Drug Administration-licensed HIV-1-screening enzyme immunoassays for detecting antibodies to HIV-2.

Authors:  J R George; M A Rayfield; S Phillips; W L Heyward; J W Krebs; K Odehouri; R Soudre; K M De Cock; G Schochetman
Journal:  AIDS       Date:  1990-04       Impact factor: 4.177

Review 9.  Syphilis and HIV infection.

Authors:  E W Hook
Journal:  J Infect Dis       Date:  1989-09       Impact factor: 5.226

10.  Monitoring blood donors for HIV-2 infection by testing anti-HIV-1 reactive sera.

Authors:  M P Busch; L Petersen; C Schable; H Perkins
Journal:  Transfusion       Date:  1990-02       Impact factor: 3.157

  10 in total
  1 in total

1.  Demographic and behavioral predictors of knowledge and HIV seropositivity: results of a survey conducted in three anonymous and free counselling and testing centers.

Authors:  I Momas; H Helal; S Prétet; L Marsal; R Poinsard
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.